Clinical Trial Update: Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating far infrared irradiation as a non-drug approach to managing and treating multiple sclerosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: GAAD Medical Research Institute Inc. | Conditions: Multiple Sclerosis | Phase 1 | Status: UNKNOWN